by Nicola Blackburn | Mar 24, 2025
Researchers at the Garvan institute have published findings revealing a promising new therapeutic target to slow down or inhibit metastasis in pancreatic cancer. The study identified a metabolic signaling molecule involved in facilitating the spread of the disease to...
by Nicola Blackburn | Jul 5, 2024
Prof Paul Timpson, head of the Invasion and Metastasis Lab, Professor Thomas Cox and Dr Brooke Pereira of the Garvan Institute of Medical Research were awarded funding from the Cancer Council to continue research into advancing treatment options for pancreatic cancer....
by Nicola Blackburn | Nov 16, 2023
Professor Anthony Gill was honoured as the winner of the 2023 Outstanding Cancer Researcher of the Year for his significant contributions to the field of cancer diagnosis and pathology. The Premier’s Awards for Outstanding Cancer Research is the highest accolade for...
by Nicola Blackburn | Nov 16, 2023
November is recognised as World Pancreatic Cancer Awareness Month where we take time to raise awareness of the disease. The theme for this year is ‘Hello Pancreas’, an engaging way of helping people to become more aware of the pancreas organ, it’s...
by Nicola Blackburn | Jul 4, 2023
Researchers at the Garvan Institute have developed a novel way to monitor drug response and resistance in pancreatic cancer, utilizing a mouse model that allows for the real time visualisation of the effect of drug treatment within tumours. The team at the Garvan...
by Nicola Blackburn | Dec 28, 2022
2022 was another year of facing and overcoming challenges for people around the world. As we move into a new year, it is a good time to reflect on achievements and accomplishments. Throughout the year, the APGI has continued to support Pancreatic Cancer research...
